Delcath Systems (DCTH) Stock: Don’t Trust White Diamond Research!


Delcath Systems, Inc. (NASDAQ: DCTH) is having a bit of a rough time in the market today. The blame for the losses can partly be placed on an article that was published on Seeking Alpha by White Diamond Research. In response to the article, I, Joshua Rodriguez, have decided to personally do a write up, as the idiots behind the cloak by the name of “White Diamond Research” decided to defame my business in their most recent article.

White Diamond Research Simply Can’t Be Trusted

In a post that was published on Seeking Alpha yesterday, White Diamond Research laid out a bearish argument for Delcath Systems. While I will admit that some of their points were valid, and if things would have gone differently I would have loved to debate with them until I was blue in the face, I have to say their research simply can’t be trusted.

In their explanation of why DCTH went from $0.02 to $0.20 per share over the past couple of months, White Diamond Research said that this was the result of paid stock promotion (something that is completely illegal without proper disclaimers). In particular, they said that CNA Finance was being paid to promote DCTH. Here’s a quote from their article…

Part of the reason why DCTH went from $0.02 to $0.20 within a couple months, before falling to $0.14, is from promotional stock websites. is one of the promoters. See its DCTH articles here.”

The article went on to quote our disclaimer, which can be viewed on the right sidebar of every page of our website, using it as evidence that we were paid by DCTH. While I will admit that we are sometimes approached and indeed paid to provide public research with regard to a stock, that is not the case here. In fact, we haven’t been paid a dime by DCTH. If we were, you would have seen an additional disclaimer at the end of the articles written about the company that explained that we were indeed paid, the amount of the payment, and who the payment came from… you know… general, ethical business practice!

Interestingly enough, as a business we keep record of who paid us, when, and for what. Had White Diamond Research pulled their figurative head out of their figurative A$$ and gave us a call, we would have provided them with detailed information on every company that has paid us and for what over the past year. However, they didn’t do that, and for that they should be ashamed.

Why I’m Excited About Delcath Systems

As mentioned above, the articles we have written surrounding DCTH have nothing to do with payment. My team and I have not received a single penny, share, or any other form of reimbursement for the articles we have written surrounding the company. So, why is it that I’m so excited about Delcath? Here’s why…

In a previous article on the company, I explained that I am excited about the fight us mere humans have waged against cancer. I lost my aunt, uncle, and stepfather to the illness, and I’m sure most reading this have lost someone they loved to it as well. During the battle, I had the opportunity to see how this disease tears down the body, mind, and soul. I witnessed agonizing pain, much of which was caused by the medication that was used to fight the illness.

Then, I was researching the latest and greatest in oncology a few months ago, and I came across DCTH. I dug in and was intrigued to say the least. You see, if you happen to have cancer and head for chemotherapy right now, you will receive treatment that invades your entire body. However, DCTH has found a way to target specific organs through catheter systems, which, in my opinion, is not only likely to improve efficacy of what we know as chemotherapy today, but also safety of the treatment.

Does Delcath have some work to do on the financial side of the coin?  Sure they do. Have they made all the right moves in the history of their company? Absolutely not!  I don’t know of any company that has. But are they worth your time? Absolutely! Here we have a company that has an approved treatment that is saving lives in Europe. They are working on 2 Phase 3 studies in the United States as we speak, and while some information may not be so positive surrounding the company, there’s no such thing as perfection – we’re all human!

The Bottom Line

The bottom line here is that I would love to be paid to get behind a great company like DCTH. However, I, nor anyone else on the CNA Finance team, has been paid a penny by the company, it’s IR firm, or anyone associated with the company. So, why do I get behind them? Because they’re a great company!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required

Previous articleYandex (YNDX) Stock: Flying On Uber Deal
Next articleHimax Technologies (HIMX) Stock: Falling Hard On Downgrade
Hey, Im Joshua, the founder of CNA Finance. I enjoy following the trends in the market and finding the catalysts that are making the moves. If you want to get in contact with me, leave a comment below or email me at Please keep in mind that I am not an investment advisor and nor is CNA Finance. This is a news and information gathering outlet. We may work directly with some of the companies that we write about. If we have a business relationship with an issuer, we will mention that in the articles. We also have various affiliate relationships with advertisers and may be paid if you sign up for a service that you were referred to through our website.


Please enter your comment!
Please enter your name here